3 ms·
Bresch became CEO of the company in Jan. 2012. Prior to that, she was a lobbyist for the company. She was appointed president in 2009. She has seen her salary i
by jessaustin 10y ago
Bresch became CEO of the company in Jan. 2012. Prior to that, she was a lobbyist for the company. She was appointed president in 2009. She has seen her salary increase from $2.4 million since 2007 to $18.9 million last year...
One indication a drug company might be in maintenance mode rather than research mode: the president and CEO is a lobbyist.
- shostack 10y agoHonest question...which do you think drives greater quarterly returns for shareholders? Guessing that is a big reason for the pay bump.